Takeda Archives - DelveInsight

Takeda

pharma-happenings-for-valo-health-ventyx-takeda-maverick-therapeutics
Valo Health receives $110M Series B Cognito’s therapy slows Alzheimer’s disease Venty...

Valo Health receives USD 110 Million Series B from KochValo Health launched in September with USD 100 million and a couple of acquisitions under its belt to transform drug development and cut ...


Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda’s Maribavir; Astellas/Seagen Padcev
Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda’s Mariba...

Merck's Keytruda-Eisai's Lenvima Combo Make the Cut in Renal CancerNumerous immunotherapy-based combinations are already trying in the old game of gleek to stake up some share in previously un...


pharma-biotech-news-and-updates-for-dna-link-base10-takeda-advaxis
BASE10 Collaboration; Advaxis Public offerings; Takeda’s CABOMETYX Japan approval; TheraPha...

BASE10 Collaborates with DNA Link for COVID-19 Antibody Test ResearchUS-based BASE10 Genetics and Korean firm DNA Link announced a collaboration on a research project to appraise the usability...


Gastroparesis market size
New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves

The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynamic pipeline therapies in...


Celiac Disease Market Key Companies
Celiac Disease: The Hidden Epidemic of Gluten Sensitivity

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving C...


Pharma News
ImaginAb joins hands with AstraZeneca, Pfizer, Takeda

ImaginAb has collaborated with AstraZeneca, Pfizer and Takeda to develop technology to facilitate tumour imaging and monitoring inside the cells.ImaginAb is an emerging imaging company focuse...


Pharma News
Turalio gets FDA approval; Sosei Heptares, Takeda forms an R&D pact

FDA approves first Tenosynovial giant cell tumour treatment Turalio (Pexidartinib)The US FDA has given its approval to Turalio (pexidartinib) capsules for the treatment of symptomatic tenosyno...


astellas
Commercial

Astellas’ Ophthalmology Innovation to Strengthen Further With Quethera AcquisitionAstellas has acquired Quethera, a gene therapy company headquartered in the UK, which is focused on developing...


Default Blog Image
Sutro nets $85.4M; HiFiBiO pens Takeda R&D collaboration

Sutro Biopharma nets $85.4M to drive antibody-drug conjugates Sutro Biopharma reeled in an $85.4 million series E that will advance some early-stage programs as well as its cancer pipeline, which i...


Therapeutics
Business Cocktail

Sanofi bags rights to Revolution’s SHP2 cancer drug Sanofi has paid $50 million to work with Revolution Medicines on the development of cancer drugs against SHP2. The partners plan to move small mo...


Editor's Pick
Top Drugs To Watch in HIV (2025)

Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) th...

An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.